Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory‐driven colon cancer

Colorectal cancer (CRC) is associated with significant morbidity and mortality in the US and worldwide. CRC is the second most common cancer‐related death in both men and women globally. Chronic inflammation has been identified as one of the major risk factors of CRC. It may drive genetic and epigenetic/epigenomic alterations, such as DNA methylation, histone modification, and non‐coding RNA regulation. Current prevention modalities for CRC are...